1. Home
  2. CPRX vs WSBC Comparison

CPRX vs WSBC Comparison

Compare CPRX & WSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • WSBC
  • Stock Information
  • Founded
  • CPRX 2002
  • WSBC 1870
  • Country
  • CPRX United States
  • WSBC United States
  • Employees
  • CPRX N/A
  • WSBC N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • WSBC Major Banks
  • Sector
  • CPRX Health Care
  • WSBC Finance
  • Exchange
  • CPRX Nasdaq
  • WSBC Nasdaq
  • Market Cap
  • CPRX 2.8B
  • WSBC 2.6B
  • IPO Year
  • CPRX 2006
  • WSBC N/A
  • Fundamental
  • Price
  • CPRX $22.52
  • WSBC $28.30
  • Analyst Decision
  • CPRX Strong Buy
  • WSBC Buy
  • Analyst Count
  • CPRX 7
  • WSBC 5
  • Target Price
  • CPRX $32.29
  • WSBC $40.20
  • AVG Volume (30 Days)
  • CPRX 1.7M
  • WSBC 827.3K
  • Earning Date
  • CPRX 05-07-2025
  • WSBC 04-29-2025
  • Dividend Yield
  • CPRX N/A
  • WSBC 5.22%
  • EPS Growth
  • CPRX 107.94
  • WSBC N/A
  • EPS
  • CPRX 1.31
  • WSBC 2.26
  • Revenue
  • CPRX $491,734,000.00
  • WSBC $586,985,000.00
  • Revenue This Year
  • CPRX $15.17
  • WSBC $45.19
  • Revenue Next Year
  • CPRX $9.61
  • WSBC $11.71
  • P/E Ratio
  • CPRX $17.19
  • WSBC $12.53
  • Revenue Growth
  • CPRX 23.49
  • WSBC 0.50
  • 52 Week Low
  • CPRX $14.47
  • WSBC $25.56
  • 52 Week High
  • CPRX $26.16
  • WSBC $37.36
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 48.15
  • WSBC 40.57
  • Support Level
  • CPRX $21.93
  • WSBC $26.42
  • Resistance Level
  • CPRX $23.27
  • WSBC $29.50
  • Average True Range (ATR)
  • CPRX 1.27
  • WSBC 1.35
  • MACD
  • CPRX -0.14
  • WSBC 0.04
  • Stochastic Oscillator
  • CPRX 50.60
  • WSBC 36.29

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).

About WSBC WesBanco Inc.

Wesbanco Inc is a bank holding company. Through its subsidiaries, it offers a full range of financial services, including retail banking, corporate banking, personal and corporate trust services, brokerage services, mortgage banking, and insurance. WesBanco operates one commercial bank, WesBanco Bank, which runs scores of branches. The company's reportable segments are Community Banking, which derives key revenue, and Trust and Investment Services. The Community Banking segment offers various banking products and services through various delivery channels, including commercial demand, individual demand, and time deposit accounts; commercial, mortgage, and individual installment loans; and certain non-traditional offerings, such as insurance and securities brokerage services.

Share on Social Networks: